Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03471429 · ClinicalTrials.gov registry record
Canine-assisted ANxiety Reduction IN Emergency
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 80
- Enrollment target
NCT03471429: Completed study, sponsored by Indiana University.
NCT03471429 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03471429 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to see if dogs can reduce the anxiety level of patients in the emergency department.
Primary Outcome
reduction in anxiety score (0-10). 0=balanced mood (least anxiety) 2= slight fear and worry 4=mild fear and worry 6= moderate worry, physical agitation 8=Feeling really bad, at the edge 10=out of control behavior, self-harm (worst anxiety)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-12-21 |
| Est. Completion | 2018-04-04 |
What the finished NCT03471429 record still lists
NCT03471429 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03471429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03471429 about?
NCT03471429 is a clinical study titled "Canine-assisted ANxiety Reduction IN Emergency". The purpose of this study is to see if dogs can reduce the anxiety level of patients in the emergency department.
What is the current status of trial NCT03471429?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2017-12-21. Estimated completion is 2018-04-04.
Who is sponsoring clinical trial NCT03471429?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI